Q J Med 2000; 93: 441-448
© 2000 Association of Physicians
Increased augmentation index and systolic stress in type 1 diabetes mellitus
From the Clinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, 1 Department of Community Health Sciences, University of Edinburgh Medical School, Edinburgh, 2 Department of Cardiology, University of Wales College of Medicine, University Hospital, Cardiff, and 3 Metabolic Unit, Western General Hospital, Edinburgh, UK
 |
Summary |
|---|
 Top Summary IntroductionMethodsResultsDiscussionReferences |
|---|
Type 1 diabetes mellitus is associated with endothelial dysfunction and increased arterial stiffness, both of which may contribute to the excess cardiovascular mortality in such patients. Arterial stiffening increases pulse wave velocity and wave reflection, which augments central systolic pressure and stress. Using the non-invasive technique of pulse wave analysis, we investigated aortic augmentation and central pressure in 35 patients with type 1 diabetes and 35 matched controls. Peripheral pulse waveforms were recorded from the radial artery. Central aortic waveforms were then generated, and augmentation index (AIx), ascending aortic pressure and tension time index (TTI), a measure of systolic load, were calculated. Peripheral and central blood pressure did not differ between the two groups. AIx was significantly elevated in the diabetic patients compared with controls (7.1±1.6% vs. 0.4±2.0%; p=0.01), as was the TTI (2307±51 mmHg.s.min-1 vs. 2010±61 mmHg.s.min-1; p<0.001). Estimated pulse wave velocity was also higher in the diabetic group. Type 1 diabetes is associated with an increased AIx and rate of wave travel, indicating enhanced wave reflection and increased systemic arterial stiffness, and elevation of the TTI. Such haemodynamic effects may contribute to the increased left ventricular mass and risk of cardiovascular disease associated with type 1 diabetes mellitus.
|
Introduction |
|---|
|
TopSummaryIntroductionMethodsResultsDiscussionReferences |
|---|
The single most common cause of death amongst diabetic patients is atherosclerotic cardiovascular disease.1,2 The risk of developing specific complications of diabetes mellitus (e.g. retinopathy, nephropathy, neuropathy) is clearly associated with the degree and duration of hyperglycaemia, but the relationship between diabetes and macrovascular disease is poorly understood.1Indeed, intensive glycaemic control does not reduce cardiovascular mortality in patients with either type 1 or type 2 diabetes mellitus.3,4Why diabetes should promote atherogenesis remains unclear, although this may be related to the association of diabetes with other risk factors including hyperlipidaemia and hypertension in the ‘metabolic syndrome’.5
Increased arterial stiffness is a feature of both type 1 and 2 diabetes, and can be detected using a variety of techniques.6 It occurs early in the course of diabetes and is not related to the presence of atheroma.7,8 Indeed, disruption of normal endothelial function may be partly responsible for arterial stiffening in diabetes.9 Mounting evidence suggests that arterial stiffness is not only an important additional and independent risk factor for cardiovascular disease, but that it may also have a role in the process of atherosclerosis itself.6,9 Therefore, assessment of arterial stiffness may improve risk stratification.
Current methods of assessing arterial stiffness, such as measurement of pulse wave velocity (PWV) or the use of ultrasound-derived indices, only provide information about compliance within a specific artery or arterial segment, and tend to be time-consuming and/or operator-dependent.10 However, the technique of pulse wave analysis (PWA) provides information about systemic arterial stiffness. Previously, PWA was limited to peripheral pressure waveforms,11 but further development of the technique by O'Rourke and colleagues has made non-invasive analysis of central pressure waves possible.12 From these waveforms central arterial pressure—and various other haemodynamic parameters including augmentation index (AIx) and the tension time index (TTI), a measure of systolic stress and, therefore, of left ventricular workload—can also be determined. The aim of the present study was to test the hypothesis that type 1 diabetes is associated with increased systemic arterial stiffness and elevated central systolic stress, in a group of otherwise healthy younger adults with diabetes and normal peripheral blood pressure.
|
Methods |
|---|
|
TopSummaryIntroductionMethodsResultsDiscussionReferences |
|---|
Patients
Thirty-five patients who had had type 1 diabetes for a minimum of 10 years were recruited from the local adult diabetic clinic at the Western General Hospital, Edinburgh. Concurrently, non-diabetic controls were recruited from a community database of volunteers held at the Western General Hospital and selected such that, as a group, their distribution of age, sex and weight closely matched the patient group. Approval for the study was obtained from the local Research Ethics Committee, and informed consent obtained from each participant. The investigation conformed to the principles outlined in the Declaration of Helsinki. All subjects were free from clinical evidence of cardiovascular disease at entry, and all diabetic subjects were receiving insulin at the time of the study. Subjects with clear evidence of hypertension (blood pressure >160/100 mmHg) or hypercholesterolaemia (total serum cholesterol >6.5 mmol/l), or those receiving any medication other than insulin, were excluded. Cigarette smokers were allowed to participate.
Peripheral blood pressure measurement
Blood pressure was recorded in duplicate in the dominant arm using a validated oscillometric technique (HEM-705CP; Omron).13 Values were reported as the mean of the two readings, and peripheral mean arterial pressure was calculated as the diastolic pressure plus one-third of the pulse pressure.
Pulse wave analysis
Central pressure waveforms were derived and analysed using the technique of PWA (SCOR; PWV Medical), as previously described.14 In brief, a high-fidelity micromanometer (SPC-301; Millar Instruments) was used, by experienced operators (DFR), to flatten, but not occlude, the radial artery of the dominant arm using gentle pressure with the wrist slightly extended and supported on a pillow. Data were collected directly into a portable microcomputer and, after 20 sequential waveforms had been acquired, an averaged peripheral waveform, and a corresponding central waveform, were generated. Recordings were excluded if the systolic or diastolic variability of the waveforms exceeded 5%, or the amplitude of the waveform, a measure of the quality of the tracing, was <100 mV. The central waveform was then analysed using the system software to determine AIx, central pressure, ejection duration, the timing of wave reflection and heart rate. AIx represents the difference between the first and second peaks of the central pressure waveform, in systole, expressed as a percentage of the pulse pressure, and is a measure of systemic arterial stiffness and wave reflection (Figure 1
). The TTI, the area under the systolic portion of the pressure waveform per min (the systolic pressure-time integral), an index of systolic stress, and the diastolic pressure-time integral were also determined (Figure 1).15,16 From these variables the subendocardial viability index (diastolic pressure-time integral divided by TTI) was calculated.17 This provides a useful measure of the relationship between subepicardial and subendocardial blood flow, and thus the potential for myocardial ischaemia.18 Ejection duration was calculated as the time from the foot of the pressure wave to the incisura. The aortic pulse wave velocity was estimated by calculating the time between the foot of the pressure wave and the inflection point, which provides a measure of the timing of the reflected wave, as described previously.19,20 All measurements were made in duplicate.
|
P, expressed as a percentage of the pulse pressure, PP. AIx is usually negative in young people, approximately zero at 35 years, and positive thereafter. The area under the systolic portion of the wave (A) is defined as the tension time index, and the diastolic area (B) the diastolic pressure time integral.
Protocol
Diabetic patients were studied whilst attending a late-afternoon diabetic clinic at the Western General Hospital, and controls were studied in the Clinical Research Centre. All were subject to an identical protocol. After 5 min seated rest in a quiet room, brachial artery pressure was determined and then radial pressure waveforms were recorded in duplicate. Venous blood was drawn, from the antecubital fossa, for measurement of plasma glucose, total serum cholesterol, triglycerides, creatinine, and HbA1c (HPLC assay; VARIANT) in the diabetic patients. Finally, height and weight were recorded, and body mass index (BMI) calculated.
Data analysis
Data were analysed using unpaired, two-tailed Student's t-tests, and multiple regression analysis (SPSS version 9.0 for Windows, linear regression, ‘forward method’). All results are presented as means±SEM unless stated otherwise, and where appropriate the confidence intervals (CIs) are quoted. A p value of 0.05 or less was taken as significant.
|
Results |
|---|
|
TopSummaryIntroductionMethodsResultsDiscussionReferences |
|---|
Thirty-five patients with type 1 diabetes, aged 30±7 years (mean±SD, range 19–45), and 35 controls, aged 30±8 years (mean±SD, range 18–50), were entered into the study. There was no significant difference in age, sex, height, weight, BMI, or the number of smokers between the two groups (Table 1
). Amongst the diabetic group, the average HbA1c was 8.8±0.2% (reference range 5.0–6.5%) and duration of diabetes was 18±1 years (range 10–32). One diabetic patient had microalbuminuria and proliferative retinopathy, a further two had evidence of background retinopathy and one evidence of proliferative retinopathy alone. Serum triglycerides and glucose were significantly elevated in the diabetic group compared with the control group. However, total serum cholesterol did not differ significantly between the two groups (Table 1).
|
The peripheral systolic pressure did not differ significantly between diabetic patients (126±2 mmHg; 95%CI 98–153 mmHg) and controls (123±2 mmHg; 95%CI 97–150 mmHg). Peripheral diastolic pressure was also similar between the two groups: diabetics 77±2 mmHg (95%CI 59–95 mmHg), controls 77±1 mmHg (95%CI 64–90 mmHg). Table 2
summarizes the results of the study, and Figure 2 shows representative ascending aortic waveforms, determined by PWA, from the two groups. Ascending aortic pressure, assessed by PWA, was not significantly different between the two groups, and neither was the ratio of peripheral to central pulse pressure. However, AIx, heart rate, and TTI were significantly higher amongst the diabetic patients compared with controls, and ejection duration and subendocardial viability index significantly lower. There was no difference in the diastolic pressure time integral between the two groups. In addition, the reflected pressure wave returned to the ascending aorta significantly earlier in the diabetic subjects compared with controls.
|
|
To investigate the factors influencing AIx in the diabetic patients, a multiple regression model was constructed with AIx as the dependent variable. Duration of diabetes, height, sex, heart rate, peripheral mean arterial pressure, HbA1c, and serum triglycerides were entered into the model. Age was not included, due to the close relationship between age and duration of diabetes, and the relatively small number of subjects used to generate the model. Duration of diabetes, short stature, low heart rate and serum triglycerides correlated positively with AIx, but there was no significant association between the other variables and AIx (Table 3
). The regression model accounted for 57% of the variance in AIx between the diabetic subjects.
|
|
Discussion |
|---|
|
TopSummaryIntroductionMethodsResultsDiscussionReferences |
|---|
Our main finding, using analysis of the derived central pressure waveform, was that AIx and TTI were elevated in the diabetic group compared with controls. AIx provides a measure of the contribution made by the reflected wave to ascending aortic pressure.21, However, since the amplitude and velocity of the reflected wave are dependent upon arterial stiffness, AIx also acts as a measure of systemic arterial stiffness.22,23, To evaluate large-artery stiffness more directly, we also calculated the timing of the reflected pressure wave, which, as previously described, provides an estimate of the aortic PWV and thus aortic stiffness.19,20 In keeping with the higher AIx, the reflected pressure wave returned to the ascending aorta sooner in the diabetic subjects, indicating a higher PWV. Taken together, these data imply enhanced wave reflection and increased systemic arterial stiffness in patients with type 1 diabetes mellitus.
A number of variables are known to influence AIx. Indeed, AIx is positively correlated with age and blood pressure, and inversely correlated with height.16,24 However, in the present study the two study groups were well matched for age, sex ratio, height, weight and serum cholesterol. Peripheral mean arterial pressure did not differ significantly between the two groups and is, therefore, unlikely to account for the increased AIx of the diabetic group. AIx is also inversely related to heart rate25 and, as expected, in the present study resting heart rate was higher in the diabetic patients, confirming previous data.26 Nevertheless, this is not a confounding factor, because such a difference would tend to decrease, rather than increase, AIx, leading to a relative underestimate of arterial stiffness in the diabetic group. Indeed, correcting for the difference in heart rate, using our own data,25 increases the observed difference in AIx from 6.7% to 10.5%; implying that, if anything, we may have underestimated arterial stiffness amongst subjects with type 1 diabetes.
Despite having a higher AIx, the diabetic subjects did not have a higher central systolic or pulse pressure. Indeed, pressure amplification (the ratio of peripheral to central pulse pressure) did not differ between the two groups. The most likely explanation for this is the relatively young age of the subjects studied and the small sample size. The average AIx in our control group was 0.4%, in keeping with the low mean age of 30±1 years23,24 and, in such a relatively young group, arterial stiffening, despite increasing wave reflection and AIx, will not initially increase systolic pressure, although it will alter the shape of the central pressure waveform. However, the TTI was higher in the diabetic group, indicating a larger area under the systolic portion of the pressure-time waveform (systolic pressure-time integral) and, therefore, increased systolic stress.15 Similar findings have been reported previously27 and may be explained by both increased arterial stiffness and a higher resting heart rate in the diabetic subjects.28,29 Interestingly, TTI appears to be a better predictor of left ventricular hypertrophy than peripheral ambulatory blood pressure30 and therefore, increased systolic load, resulting, in part, from systemic arterial stiffening may help explain the higher left ventricular mass reported in normotensive type 1 diabetic subjects.31–33 However, since we did not assess left ventricular mass in the present study we cannot directly confirm this.
In contrast, the diastolic pressure-time integral did not differ between the two study groups. This may be explained by a higher average heart rate in the diabetic subjects leading to an increased number of diastolic filling periods per minute, but a decrease in the absolute duration of each one, resulting in no overall change in diastolic pressure-time integral. As a consequence of these haemodynamic alterations, subendocardial viability index was reduced in the diabetic subjects, indicating a greater propensity to myocardial ischaemia.18 Importantly, as in the present study, such haemodynamic changes may not necessarily result in a raised peripheral systolic pressure. This re-emphasizes the importance of assessment of the central waveform.
Our results support previous studies, using peripheral PWA, which demonstrated increased arterial stiffness in patients with type 1 diabetes,34,35 and indicate that similar abnormalities occur in the central waveform. Brooks et al.27 have also reported an increase in AIx in patients with type 1 diabetes compared with a control group, but this difference was only apparent after adjustment for various confounding factors, and, unlike in our study, the two groups were not well-matched for key baseline characteristics known to influence AIx such as height and peripheral blood pressure.
Arterial stiffening has been demonstrated in association with type 1 diabetes by a variety of other methods, including ultrasound.9 Some, but not all studies, have suggested a correlation between arterial stiffness and the degree of glycaemic control, as assessed by HbA1c.36 However, in the present study there was no significant correlation between HbA1c and AIx in the multiple regression analysis performed for the diabetic group. More recently, the Edinburgh Artery Study Group reported a close relationship between the prevalence of peripheral vascular disease in diabetic patients, and both systolic blood pressure and serum triglycerides.37 Although we were unable to demonstrate any correlation between AIx and peripheral blood pressure in those individuals with diabetes, there was a significant association with serum triglycerides. We deliberately excluded individuals with clinical evidence of macrovascular disease (including peripheral vascular disease), or other cardiovascular risk factors, apart from cigarette smoking, and elected to study a relatively young cohort, which makes it unlikely that atherosclerosis per se explains the increased arterial stiffness in our diabetic group. Indeed, previous studies have reported arterial stiffening in children with diabetes,11,35,38 and in healthy subjects with a family history of diabetes.39
Stiffening of the arterial tree, whether due to ageing, diabetes or other cardiovascular risk factors, has important haemodynamic consequences, including an increase in the TTI, a predisposition to left ventricular hypertrophy, reduced shear stress, and ultimately a widening of the pulse pressure.40 Such changes occur because of an alteration in the shape of the pressure waveform, and augmentation of central systolic pressure and stress, as shown in the current study. The importance of arterial stiffness is emphasized by the correlation between aortic stiffness and the degree of coronary artery disease at angiography,41 and recent data indicating that pulse pressure, a surrogate marker of arterial stiffness,42 and aortic PWV43,44 are both important independent predictors of cardiovascular events.
In summary, we have confirmed earlier observations that arterial stiffness is increased in patients with type 1 diabetes who do not have clinical evidence of atheromatous disease. In addition, we have extended these earlier findings by demonstrating that systolic stress is increased amongst type 1 diabetic patients compared with matched controls. Increased systolic stress may explain the raised left ventricular mass reported in normotensive subjects with type 1 diabetes mellitus, and contribute to the excess mortality associated with this condition. PWA is to be included in the ASCOT Study,45 a trial of different antihypertensive regimens, the SEARCH Study, which will address the desirable degree of cholesterol reduction, and the European FIELD study of insulin treatment in type 2 diabetes. These studies will address the importance of arterial stiffness as a predictor of risk, and provide data about the effect of treatment on stiffness and outcome. However, at present, no studies are planned to assess the importance of arterial stiffness as a risk predictor in patients with type 1 diabetes mellitus. Clearly, the available evidence would suggest that such a trial is required.
|
Acknowledgments |
|---|
We would like to thank Mr N. Johnston, Dr I. Megson for technical assistance, and Mr P. Hupperetz and Mr C. van Thoor for aid with data collection. This study was partly funded by the High Blood Pressure Foundation. Dr I.B. Wilkinson, Dr J.R. Cockcroft and Professor D.J. Webb are supported by a Biomedical Research Collaboration Grant from the Wellcome Trust (056223). Professor D.J. Webb is currently in receipt of a Research Leave Fellowship from the Wellcome Trust (052633).
|
Notes |
|---|
Address correspondence to Dr I.B. Wilkinson, Clinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU. e-mail: i.wilkinson{at}ed.ac.uk
|
References |
|---|
|
TopSummaryIntroductionMethodsResultsDiscussionReferences |
|---|
1. Wingard DL, Barrett-Connor E. Chapter 19. Heart disease and diabetes. In: Harris MI, ed. National Diabetes Data Group: Diabetes In America, 2nd edn. Washington DC, NIH, 1995:429–48.
2. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AWM, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H. The British Diabetic Association Cohort Study, II: Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabetic Med1999; 16:466–71.[Web of Science][Medline]
3.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med1993; 329:977–86.
4. The UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type II diabetes (UKPDS:33). Lancet1998; 352:837–53.[Web of Science][Medline]
5. Reaven G. Role of insulin resistance in human disease. Diabetes1988; 37:1595–607.[Abstract]
6.
Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor. Am J Epidemiol1994; 140:669–82.
7. Oxlund H, Rasmussen LM, Andreassen TT, Heickendorff L. Increased aortic stiffness in patients with type I (insulin-dependent) diabetes mellitus. Diabetologia1989; 32:748–52.[Web of Science][Medline]
8.
Wollam G, Schnur P, Vallbona C, Hoff H. The pulse wave velocity as an early indicator of atherosclerosis in diabetic subjects. Circulation1962; 25:533–9.
9. Glasser SP, Arnett DK, McVeigh GE, Finkelstein SM, Bank AJ, Morgan DJ, Cohn JN. Vascular compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens1997; 10:1175–89.[Web of Science][Medline]
10. Cockcroft JR, Wilkinson IB. Vessel wall properties and cardiovascular risk. J Hum Hypertens1998; 12:343–4.[Web of Science][Medline]
11.
Feinberg AW, Lax H. Abnormalities in the arterial pulse wave in young diabetic subjects. Circulation1959; 20:1106–10.
12. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens1996; 14:147–57.[Web of Science][Medline]
13. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monitoring1996; 1:55–61.[Medline]
14. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ. The reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens1998; 16:2079–84.[Web of Science][Medline]
15. Sarnoff SJ, Braunwald E, Welch GH, Case RB, Stainsby WN, Marcruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension time index. Am J Physiol1958; 192:148–56.
16. Hayward CS, Kelly RP. Gender-related differences in the central arterial pressure waveform. J Am Coll Cardiol1997; 30:1863–71.[Abstract]
17.
Buckberg GD, Fixler DE, Archie JP, Hoffman JIE. Experimental subendocardial ischaemia in dogs with normal coronary arteries. Circ Res1972; 30:67–81.
18. Buckberg GD, Towers B, Paglia DE. Subendocardial ischaemia after cardiopulmonary bypass. J Thoracic Cardiovasc Surg1972; 64:669–84.[Web of Science][Medline]
19.
Murgo JP, Westerhof N, Giolma JP, Altobelli SA. Aortic input impedance in normal man: relationship to pressure waveforms. Circulation1980; 62:105–16.
20.
Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar M, London GM. Wave reflections and cardiac hypertrophy in chronic uremia. Hypertension1993; 22:876–83.
21. O'Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens1993; 11:327–37.[Web of Science][Medline]
22.
O'Rourke MF. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension1990; 15:339–47.
23. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, 4th edn. London, Arnold, 1998.
24.
Kelly RP, Hayward C, Avolio AP, O'Rourke MF. Non-invasive determination of age-related changes in the human arterial pulse. Circulation1989; 80:1652–9.
25.
Wilkinson IB, MacCallum H, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol2000; 525:263–70.
26. Facchini FS, Stoohs RA, Reaven GM. Enhanced sympathetic nervous system activity: the linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens1996; 9:1013–17.[Web of Science][Medline]
27.
Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care1999; 22:1722–7.
28.
Sowton GE, Cross D, Frick MH. Measurement of the angina threshold using atrial pacing. Cardiovasc Res1967; 1:301–7.
29. Lewis T. The factors influencing the prominence of the dicrotic notch. J Physiol1906; 34:414–29.
30. Gatzka CD, Schmieder RE, Schobel HP, Klingbeil AU, Weihprecht H. Improved prediction of left ventricular mass from ambulatory blood pressure monitoring using average tension-time index. J Hypertens1993; 11:98–9.
31. Gambardella S, Frontoni S, Spallone V, Maiello M, Civetta E, Lanza G, Sandric S, Menzinger G. Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens1993; 6:97–102.[Web of Science][Medline]
32.
Kimball T, Daniels S, Khoury P, Magnotti R, Turner A, Dolan L. Cardiovascular status in young patients with insulin-dependent diabetes mellitus. Circulation1994; 90:357–61.
33. Lee M, Gardin J, Smith V-E, Tracy R, Savage P, Szklo M, Ward V. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. Am Heart J1997; 133:36–43.[Web of Science][Medline]
34. Lax H, Feinberg AW, Cohen BM. Studies of the arterial pulse wave. J Chron Dis1956; 3:618–31.[Medline]
35. Pillsbury H, Hung W, Kyle M, Freis E. Arterial pulse waves and velocity and systolic time intervals in diabetic children. Am Heart J1974; 87:783–90.[Web of Science][Medline]
36. Jensen-Urstad K, Reichard P, Rosors J, Jensen-Urstad M. Early atherosclerosis is retarded by improved long-term glucose control in patients with IDDM. Diabetes1996; 45:1253–8.[Abstract]
37. MacGregor AS, Price JF, Hau CM, Lee AJ, Carson MN, Fowkes FGR. Role of systolic blood pressure and plsama triglycerides in diabetic peripheral-arterial disease: The Edinburgh Artery Study. Diabetes Care1999; 22:453–8.[Abstract]
38. Feinberg AW, Lax H. Vascular abnormalities in children with diabetes mellitus. JAMA1967; 201:105–8.
39. Gunn GC, Dobson HL, Gray J, Geddes LA, Vallbona C. Studies of pulse wave velocity in potential diabetic subjects. Diabetes1965; 14:489–92.
40.
Cockcroft JR, Wilkinson IB, Webb DJ. The Trevor Howell Lecture: age, arterial stiffness and the endothelium. Age Ageing1997; 26:53–60.
41.
Hirai T, Sasayama S, Kawasaki T, Yagi S-I. Stiffness of systemic arteries in patients with myocardial infarction. Circulation1989; 80:78–86.
42.
Benetos A, Safar M, Rudnichi A, Smulyan H, Richard J-L, Ducimetiere P, Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension1997; 30:1410–15.
43.
Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension1999; 33:1111–17.
44.
Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar M, London G. Impact of aortic stiffness on survival in end-stage renal disease. Circulation1999; 99:2434–9.
45. Loshak D. The race is on in hypertension. Br J Cardiol1997; 4:179.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. E Davies, K. H Parker, D. P Francis, A. D Hughes, and J. Mayet What is the role of the aorta in directing coronary blood flow? Heart, December 1, 2008; 94(12): 1545 - 1547. [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Smith and P. J. Levy Review: New techniques for assessment of vascular function Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 373 - 385. [Abstract] [PDF]
|
|
|
|
 |
|
 M. L. Macedo, D. Luminoso, M. D. Savvidou, C. M. McEniery, and K. H. Nicolaides Maternal Wave Reflections and Arterial Stiffness in Normal Pregnancy as Assessed by Applanation Tonometry Hypertension, April 1, 2008; 51(4): 1047 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Munir, A. Guilcher, T. Kamalesh, B. Clapp, S. Redwood, M. Marber, and P. Chowienczyk Peripheral Augmentation Index Defines the Relationship Between Central and Peripheral Pulse Pressure Hypertension, January 1, 2008; 51(1): 112 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Sommerfield, I. B. Wilkinson, D. J. Webb, and B. M. Frier Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1274 - E1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Qiu, C. Depre, K. Ghosh, R. G. Resuello, F. F. Natividad, F. Rossi, A. Peppas, Y.-T. Shen, D. E. Vatner, and S. F. Vatner Mechanism of Gender-Specific Differences in Aortic Stiffness With Aging in Nonhuman Primates Circulation, August 7, 2007; 116(6): 669 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G Casey, M. Joyce, K. Moore, C. Thompson, P. Fitzgerald, and D. J Bouchier-Hayes Two-week treatment with pravastatin improves ventriculo-vascular haemodynamic interactions in young men with type 1 diabetes Diabetes and Vascular Disease Research, March 1, 2007; 4(1): 53 - 61. [Abstract] [PDF]
|
|
|
|
 |
|
 K. G. Soucy, S. Ryoo, A. Benjo, H. K. Lim, G. Gupta, J. S. Sohi, J. Elser, M. A. Aon, D. Nyhan, A. A. Shoukas, et al. Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness J Appl Physiol, December 1, 2006; 101(6): 1751 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Sharman, Z. Y. Fang, B. Haluska, M. Stowasser, J. B. Prins, and T. H. Marwick Left Ventricular Mass in Patients With Type 2 Diabetes Is Independently Associated With Central but not Peripheral Pulse Pressure Diabetes Care, April 1, 2005; 28(4): 937 - 939. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Haller, M. Samyn, W. W. Nichols, T. Brusko, C. Wasserfall, R. F. Schwartz, M. Atkinson, J. J. Shuster, G. L. Pierce, and J. H. Silverstein Radial Artery Tonometry Demonstrates Arterial Stiffness in Children With Type 1 Diabetes Diabetes Care, December 1, 2004; 27(12): 2911 - 2917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Hope, D. B. Tay, I. T. Meredith, and J. D. Cameron Use of Arterial Transfer Functions for the Derivation of Central Aortic Waveform Characteristics in Subjects With Type 2 Diabetes and Cardiovascular Disease: Response to Wilkinson and McEniery and Avolio, Cockcroft, and O'Rourke Diabetes Care, October 1, 2004; 27(10): 2565 - 2567. [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Mullan, C. N. Ennis, H. J. P. Fee, I. S. Young, and D. R. McCance Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1262 - H1268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mather and R. Lewanczuk Measurement of Arterial Stiffness in Diabetes: A cautionary tale Diabetes Care, March 1, 2004; 27(3): 831 - 833. [Full Text] [PDF]
|
|
|
|
 |
|
 R Klocke, J R Cockcroft, G J Taylor, I R Hall, and D R Blake Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis Ann Rheum Dis, May 1, 2003; 62(5): 414 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Millasseau, S. J. Patel, S. R. Redwood, J. M. Ritter, and P. J. Chowienczyk Pressure Wave Reflection Assessed From the Peripheral Pulse: Is a Transfer Function Necessary? Hypertension, May 1, 2003; 41(5): 1016 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Oliver and D. J. Webb Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 554 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Chang, K.-L. Hsu, and Y.-Z. Tseng Effects of Diabetes and Gender on Mechanical Properties of the Arterial System in Rats: Aortic Impedance Analysis Experimental Biology and Medicine, January 1, 2003; 228(1): 70 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Mullan, I. S. Young, H. Fee, and D. R. McCance Ascorbic Acid Reduces Blood Pressure and Arterial Stiffness in Type 2 Diabetes Hypertension, December 1, 2002; 40(6): 804 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Asmar, P. Gosse, J. Topouchian, G. N'tela, A. Dudley, and G. L Shepherd Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension Journal of Renin-Angiotensin-Aldosterone System, September 1, 2002; 3(3): 176 - 180. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Soderstrom, G. Nyberg, M. F. O'Rourke, J. Sellgren, and J. Ponten Can a clinically useful aortic pressure wave be derived from a radial pressure wave?{dagger} Br. J. Anaesth., April 1, 2002; 88(4): 481 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. B. Wilkinson, D. J. Webb, J. R. Cockcroft, S. Kinlay, P. Ganz, and M. A. Creager Nitric Oxide and the Regulation of Arterial Elasticity: Right Idea, Wrong Vascular Bed? Hypertension, April 1, 2002; 39 (4): e26 - e27. [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. G. Kelly, A. Speirs, G. W. Gould, J. R. Petrie, H. Lyall, and J. M. C. Connell Altered Vascular Function in Young Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 742 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Siebenhofer, A.J. Sutton, B. Williams, I.B. Wilkinson, J.R. Cockcroft, and D.J. Webb QJM, December 1, 2000; 93(12): 839 - 841. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||